Nasal administration of low molecular weight heparin
- 1 July 2002
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 91 (7) , 1707-1714
- https://doi.org/10.1002/jps.10171
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The biopharmaceutical aspects of nasal mucoadhesive drug deliveryJournal of Pharmacy and Pharmacology, 2001
- Enhanced Bioavailability of Calcitonin Formulated with Alkylglycosides Following Nasal and Ocular Administration in RatsPharmaceutical Research, 2001
- Interaction of membrane proteins and lipids with solubilizing detergentsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2000
- Assessment of low-molecular-weight heparin trials in cardiologyPharmacology & Therapeutics, 2000
- Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?Journal of the American College of Cardiology, 2000
- Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayersJournal of Pharmaceutical Sciences, 1999
- Enhanced Permeability of Insulin across the Rat Intestinal Membrane by Various Absorption Enhancers: Their Intestinal Mucosal Toxicity and Absorption-enhancing Mechanism of n-Lauryl-β-D-maltopyranosideJournal of Pharmacy and Pharmacology, 1999
- Systemic Absorption of Insulin and Glucagon Applied Topically to the Eyes of Rats and a Diabetic DogJournal of Ocular Pharmacology and Therapeutics, 1995
- Detection of the Low Molecular Weight Heparin Component of ITF 1300 in Urines After Intranasal Administration to DogsSeminars in Thrombosis and Hemostasis, 1994
- Low molecular weight heparinBlood, 1992